Table 1.
Target | Treatment |
---|---|
Obesity | Weight loss |
- Diet with or without exercise | |
- Pharmacologic | |
• Orlistat | |
• Sibutramine | |
- Surgical treatment of obesity | |
Insulin resistance | Insulin sensitizing agents |
- Thiazolidinediones (TZDs) | |
- Metformin | |
- Meglitinides | |
Dyslipidemia | Lipid lowering agents |
- Statins | |
- Fibrates | |
- Omega-3 fatty acids | |
Oxidative stress | Antioxidants |
- Vitamin E | |
- Other vitamins | |
- Betaine | |
- N-Acetyl-cysteine | |
- Lecithin | |
- Silymarin | |
- Beta-carotene | |
Pro-inflammatory cytokines | Anti-tumor necrosis factor agents |
- Pentoxifylline | |
Bacterial overgrowth | Probiotics |
- VSL#3 | |
Apoptosis | Cytoprotective agents |
- Ursodeoxycholic acid (UDCA) | |
Novel treatments | |
- ACE inhibitors/ARBs | |
- Oligofructose | |
- Incretin analogs |
ACE, angiotensin-converting enzyme; ARBs, angiotensin receptor blockers